glycoprotein (SPI) is said to be found only in sera of pregnant females. In this paper, SPI in the sera of malignant tumor patients was investigated by means of Ouchterlony's method and counter immunoelectrophoresis (CIEP). On the examination by Ouchterlony's method, all samples were negative, but by CIEP, 34 out of 90 samples (38%) showed positive reaction; 25 out of 61 (41%) in males and 9 out of 29 (31%) in females. There was no indication that the patients with a certain type of cancer tend to have a high incidence of SPI, but the examination of SPl in the sera of patients with cancer or suspicious cancer had some clinical significance.
SPl; cancer A specific protein in sera of pregnant females was reported by Smithies (1959) and Afonso and Farnham (1962) , which is called pregnancy-associated globulin (PAG) or pregnancy associated alpha macroglobulin (PAM). This protein was also found in sera of males and non-pregnant females (Kasukawa et al. 1973; Sagisaka and Takahashi 1976) . Stimson (1975a, b) investigated PAM in patients with cancer and found a good correlation between the PAM level and the course of the disease. Another pregnancy-specific protein originating from the placenta was found in beta region by Bohn (1971) and it was called pregnancy-specific beta-1-alycoprotein (SPI). The SPI in patients with malignant diseases was examined by Bohn and Becker (1976) and they observed no sample with positive reaction.
[n this paper, the SPl in the sera of malignant tumor patients was studied.
MATERIALS AND METHODS
A total of 90 samples (male 61, female 29) were collected from patients diagnosed of malignancy by biopsy or autopsy at the Second Department of Internal Medicine, Iwate Medical University Hospital.
Normal sera and sera of pregnant women were provided from Akita Red Cross Blood Center and the delivery room of Akita University Hospital, respectively.
Ouchterlony's method and counter immunoelectrophoresis (CIEP) were performed following the usual technique as described by Sagisaka and Takahashi (1975) . 
RESULTS
The SPl positive incidences in various types of cancers are given in Table 1 . On the examination with CIEP, 34 out of 90 samples (38%) showed positive reaction, but with Ouchterlony's method all of them were negative. The incidence of SPl was 41% in males (25 out of 61) and 31% in females (9 out of 29). The numbers of patients with lung cancer, stomach cancer, acute myelogenous leukemia, multiple myeloma and reticulosarcoma were 10 or more, and in a total of 63 patients with these five diseases, the positive incidence was 33%, but it was not found that a certain type of cancer tends to have a high incidence of SP1.
All normal sera did not react to the anti-SP1 serum at all in CIEP, while 41 out of 42 sera in pregnancy showed positive reaction.
DISCUSSION
It was found by Stimson (1975a, b) that the concentration of PAM in the patients with cancer reflected the course of the disease. On the other hand, the absence of SP1 in the sera of patients with cancer was reported by Bohn and Becker (1976) . In our study on SP1 in the patients with various types of cancers, the incidence of SP1 was 38% (34 out of 90 samples) by CIEP, and the difference in incidence between males (41%) and females (31%) was not statistically significant. In the five types of cancer mentioned above, the incidence ranged from 30 to 40% and there was no significant relation with sexes or types of cancer.
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